Workflow
仟源医药:股东赵群增持208万股成单一第一大股东

Group 1 - The core point of the article is that Zhao Qun, a major shareholder and the president of Qianyuan Pharmaceutical, increased his stake in the company, becoming the largest single shareholder [1] - Zhao Qun acquired 2,079,900 shares through centralized bidding from September 11 to 12, 2025, representing 0.84% of the total share capital [1] - After the acquisition, Zhao Qun holds a total of 15,781,792 shares, which is 6.36% of the company [1] Group 2 - Zhao Qun's action was supported by his concerted action partner, Huang Lequn, who holds 5,465,060 shares, accounting for 2.20% of the total shares [1] - Together, Zhao Qun and Huang Lequn own a combined total of 8.56% of the company [1] - Following this change, the company still has no actual controller or controlling shareholder [1]